Recently, studies have found that BCR/ABL was involved in many signaling pathways, including the PI3K/AKT, Ras and JAK/STAT signaling pathways, which are activated by BCR/ABL, resulting in malignant proliferation of CML cells. This evidence concerns the gene SOAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.